Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Mesa Laboratories
MLAB
FX & Other Adjustments
FX & Other Adjustments at other companies
3M
MMM
-$35M
-163%
Charles River Laboratories
CRL
-$18.55M
-160%
Bio-Rad Laboratories
BIO
—
—
Revvity
RVTY
—
—
Transcat
TRNS
—
—
Segments
By segment
See full
Biopharmaceutical Development
$725K
—
Clinical Genomics
$0
+100%
Other financials
Income statement
See full
Revenue
$63.7M
+2.6%
Gross profit
$31.2M
-0.5%
Operating income
-$664.0K
+85.5%
Net income
$3.6M
+317%
EPS (diluted)
-$0.10
+63.0%
Balance sheet
See full
Cash & equivalents
$26.9M
-1.4%
Total debt
$78.7M
-53.1%
Total equity
$186.2M
+16.5%
Total assets
$427.7M
-1.3%
Cash flow
See full
Operating cash flow
$14.0M
+10.2%
CapEx
$417.0K
-44.9%
Free cash flow
$13.5M
+13.7%
Valuation
See full
Market cap
$542.27M
+3.7%
Enterprise value
$594.05M
-10.4%
P/S
2.2×
0.0×
Profitability
See full
Gross margin
56.8%
—
Operating margin
2.3%
—
Net margin
1.5%
+0.8pp
FCF margin
15.9%
-1.8pp
Returns & leverage
See full
Return on equity
2.2%
+1.1pp
Debt / equity
0.4×
-0.6×
Current ratio
1.7×
+1.1×
